How effective is Viracept for Hiv Infection? (a real world drug study)
Summary:
Overall ratings: 4.2/5 Long term ratings: 4.5/5
This is a phase IV clinical study of how effective Viracept (nelfinavir mesylate) is for Hiv infection and for what kind of people. The study is created by eHealthMe from 5 Viracept users and is updated continuously.
What is Viracept?
Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,399 Viracept users. Check the latest studies of Viracept.
What is Hiv infection?
Hiv infection is found to be associated with 210 drugs and 532 conditions by eHealthMe. Check the latest studies of Hiv infection.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
5 people are studied for taking Viracept in Hiv infection
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Viracept effectiveness for Hiv infection (number of people):
Overall:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 2
- very high: 2
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 0
- high: 2
- very high: 2
Gender of people who take Viracept for Hiv infection *:
- female: 40 %
- male: 60 %
Age of people who take Viracept for Hiv infection *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 20 %
- 30-39: 0.0 %
- 40-49: 20 %
- 50-59: 40 %
- 60+: 20 %
Who find Viracept more effective for Hiv Infection?
Gender of people who take Viracept for Hiv infection *:
- female: 25 %
- male: 75 %
Age of people who take Viracept for Hiv infection *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 25 %
- 50-59: 50 %
- 60+: 25 %
* Approximation only. Some reports may have incomplete information.
Do you take Viracept?
- You can start a phase IV clinical trial to monitor Viracept safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Viracept (6,399 reports)
Treatments, associated drugs and conditions:
- Hiv infection (176,056 reports)
How the study uses the data?
The study is based on nelfinavir mesylate (the active ingredients of Viracept) and Viracept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tofacitinib Citrate cause Swelling? - now
- Lopurin and Gengraf drug interactions for men aged 50-59 - 8 seconds ago
- Drug interactions of Cosopt and Orencia - 11 seconds ago
- Sepsis and Activated Partial Thromboplastin Time Prolonged - 14 seconds ago
- Polymyalgia Rheumatica and drugs of ingredients of rivaroxaban - 22 seconds ago
- Arava and Heat Stroke for Women aged 50-59 - 23 seconds ago
- Arava and Body Overheating for Women aged 50-59 - 23 seconds ago
- Arava and Pyrexia for Women aged 50-59 - 24 seconds ago
- Could Jakafi cause Gastroesophageal Reflux Disease? - 24 seconds ago
- Arava and Hyperthermia for Women aged 50-59 - 24 seconds ago